Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Urgent Drug Recall of Ranitidine Tablets, USP, 150mg


URGENT: DRUG RECALL ADDITIONAL LOTS   


  

Description NDC Lots Exp. Date
Ranitidine 150 mg tab 65162025306 AR171764A 11/1/2019
Ranitidine 150 mg tab 65162025306 AR171875A 11/1/2019
Ranitidine 150 mg tab 65162025306 AR171876A 11/1/2019
Ranitidine 150 mg tab 65162025306 AR171981A 11/1/2019
Ranitidine 150 mg tab 65162025306 AR180020C 1/1/2020
Ranitidine 150 mg tab 65162025306 AR180206A 1/1/2020
Ranitidine 150 mg tab 65162025306 AR180207A 1/1/2020
Ranitidine 150 mg tab 65162025306 AR180208A 1/1/2020
Ranitidine 150 mg tab 65162025306 AR180438A 2/1/2020
Ranitidine 150 mg tab 65162025306 AR180439A 2/1/2020
Ranitidine 150 mg tab 65162025306 AR180481A 3/1/2020
Ranitidine 150 mg tab 65162025306 AR180482A 3/1/2020
Ranitidine 150 mg tab 65162025306 AR180483A 3/1/2020
Ranitidine 150 mg tab 65162025306 AR190058A 12/1/2020
Ranitidine 150 mg tab 65162025306 AR190059A 12/1/2020

Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Additional Lots Drug Recall of Ranitidine Tablets, USP, 150mg to the Consumer level. The recall is due to possible presence of N-nitrosodimethylamine (NDMA) Impurity. A listing of the NDC with the impacted additional lot numbers are identified. Affected product started shipping August 2018.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to the use of this drug product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Contact:

Amneal Pharmaceuticals: Amneal Stericycle 866-918-8768